As of 11:22am ET
| +0.41 / +2.74%|
The 1 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +159.74% increase from the last price of 15.40.
The current consensus among 1 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.